379 related articles for article (PubMed ID: 33639037)
1. Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia.
Nazy I; Jevtic SD; Moore JC; Huynh A; Smith JW; Kelton JG; Arnold DM
J Thromb Haemost; 2021 May; 19(5):1342-1347. PubMed ID: 33639037
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies.
Brodard J; Kremer Hovinga JA; Fontana P; Studt JD; Gruel Y; Greinacher A
J Thromb Haemost; 2021 May; 19(5):1294-1298. PubMed ID: 33550713
[TBL] [Abstract][Full Text] [Related]
4. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
5. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
7. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
8. Serotonin Release Assay: Functional Assay for Heparin- and Vaccine-Induced (Immune) Thrombotic Thrombocytopenia.
Kondo M; Donikian D; Brighton TA
Methods Mol Biol; 2023; 2663():463-477. PubMed ID: 37204730
[TBL] [Abstract][Full Text] [Related]
9. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
12. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
14. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia.
Rubino JG; Arnold DM; Warkentin TE; Smith JW; Kelton JG; Nazy I
J Thromb Haemost; 2021 Apr; 19(4):1096-1102. PubMed ID: 33387395
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
17. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.
Rollin J; Charuel N; Gruel Y; Billy S; Guéry EA; May MA; Pouplard C; Vayne C
J Thromb Haemost; 2022 Nov; 20(11):2646-2655. PubMed ID: 35971886
[TBL] [Abstract][Full Text] [Related]
18. Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia.
Favaloro EJ; Pasalic L; Henry B; Lippi G
Pathology; 2022 Apr; 54(3):254-261. PubMed ID: 35125202
[TBL] [Abstract][Full Text] [Related]
19. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
20. [Heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia: novel insights on anti-platelet factor 4 antibodies].
Atsushi Y
Rinsho Ketsueki; 2022; 63(9):1233-1241. PubMed ID: 36198549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
